{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T21:52:28Z","timestamp":1718574748510},"reference-count":19,"publisher":"FapUNIFESP (SciELO)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Soc. Bras. Med. Trop."],"published-print":{"date-parts":[[2011,2]]},"abstract":"<jats:p>INTRODU\u00c7\u00c3O: AIDS \u00e9 uma doen\u00e7a causada pelo HIV que compromete o sistema imune do organismo. O advento da terapia antirretroviral (TARV) altamente eficaz promoveu melhora substancial do progn\u00f3stico da doen\u00e7a e da qualidade de vida dos pacientes com HIV\/AIDS. Durante seu tratamento prolongado, notam-se algumas altera\u00e7\u00f5es hematol\u00f3gicas, dentre elas, anemia e macrocitose, bem como car\u00eancias de micronutrientes, tais como, de vitamina B12 e \u00e1cido f\u00f3lico. O objetivo do presente trabalho \u00e9 relacionar a macrocitose e anemia ao uso de TARV, ou \u00e0 defici\u00eancia de vitamina B12 ou de \u00e1cido f\u00f3lico. M\u00c9TODOS: Foram avaliados 110 pacientes HIV positivos, comparando-se aqueles em uso de TARV com zidovudina (AZT) (grupo 1), TARV sem AZT (grupo 2) ou sem uso de TARV (grupo 3). RESULTADOS: Os pacientes dos tr\u00eas grupos n\u00e3o apresentaram diferen\u00e7as estat\u00edsticas significativas quanto aos n\u00edveis de hemoglobina (p = 0,584) e de \u00e1cido f\u00f3lico (p = 0,956). Os pacientes do grupo 1 (G1) apresentaram volume corpuscular m\u00e9dio (VCM) aumentado quando comparado ao grupo 3 (G3) (p &lt; 0,05), bem como do grupo 2 (G2) em rela\u00e7\u00e3o ao G3 (p &lt; 0,001). As dosagens de vitamina B12 do G1 e G3 foram menores do que as encontradas pelo G2 (p = 0,008). CONCLUS\u00d5ES: Conclui-se que os indiv\u00edduos em uso de TARV apresentaram macrocitose, embora n\u00e3o pudesse ser relacionada ao tipo de TARV ou a defici\u00eancia de vitamina B12. Entretanto, a defici\u00eancia de \u00e1cido f\u00f3lico n\u00e3o esteve relacionada ao uso de TARV e nem \u00e0 macrocitose.<\/jats:p>","DOI":"10.1590\/s0037-86822011000100009","type":"journal-article","created":{"date-parts":[[2011,4,16]],"date-time":"2011-04-16T01:13:38Z","timestamp":1302916418000},"page":"35-39","source":"Crossref","is-referenced-by-count":3,"title":["Impacto do tratamento antirretroviral na ocorr\u00eancia de macrocitose em pacientes com HIV\/AIDS do munic\u00edpio de Maring\u00e1, Estado do Paran\u00e1"],"prefix":"10.1590","volume":"44","author":[{"given":"Odete Correia Antunes de","family":"Oliveira","sequence":"first","affiliation":[{"name":"Universidade Estadual Paulista"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon Antunes de","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenice do Ros\u00e1rio de","family":"Souza","sequence":"additional","affiliation":[{"name":"Universidade Estadual Paulista"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","series-title":"Boletim Epidemiol\u00f3gico AIDS","year":"2008"},{"key":"ref2","series-title":"Banco de dados do Munic\u00edpio de Maring\u00e1-PR: Perfil Epidemiol\u00f3gico de AIDS em Maring\u00e1 nos anos de 2007 e 2008"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1590\/S0021-75572001000600014","article-title":"Aspectos cl\u00ednicos e o hemograma em crian\u00e7as expostas ao HIV-1: compara\u00e7\u00e3o entre pacientes infectados e soro-reversores","volume":"77","author":"Silva EB","year":"2001","journal-title":"J Pediatr","ISSN":"http:\/\/id.crossref.org\/issn\/0022-3476","issn-type":"print"},{"key":"ref4","first-page":"229","article-title":"Adverse effects of antiretroviral therapy for HIV infection","volume":"170","author":"Montessori V","year":"2004","journal-title":"CMAJ","ISSN":"http:\/\/id.crossref.org\/issn\/0820-3946","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2310\/6650.2001.33967","article-title":"Pathogenesis of anemia during human immunodeficency virus infection","volume":"49","author":"Semba RD","year":"2001","journal-title":"J Investig Med","ISSN":"http:\/\/id.crossref.org\/issn\/1081-5589","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/01.qai.0000134759.01684.27","article-title":"Impact of active antiretroviral therapy on anemia and relationship between anemia and survival in HIV infected women","volume":"37","author":"Berhane K","year":"2004","journal-title":"J Acquir Immune Defic Syndr","ISSN":"http:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1054\/blre.2002.0193","article-title":"Pathogenesis and treatment of anaemia of chronic disease","volume":"16","author":"Weiss G","year":"2002","journal-title":"Blood Rev","ISSN":"http:\/\/id.crossref.org\/issn\/0268-960X","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/108729102760330245","article-title":"Macrocytosis as an indicator of medication zidovudine adherence in patientes with HIV infection","volume":"16","author":"Romanelli F","year":"2002","journal-title":"AIDS Patient Care STDS","ISSN":"http:\/\/id.crossref.org\/issn\/1087-2914","issn-type":"print"},{"key":"ref9","first-page":"181","article-title":"Micronutrients and pathogenesis of AIDS infection","volume":"81","author":"Semba R","year":"1999","journal-title":"BRJ Nutricion"},{"key":"ref10","first-page":"150","article-title":"Zidovudine-induced macrocytosis as a marker of antiretroviral adherence in HIV-positive patients","volume":"39","author":"Jennings HJ","year":"1999","journal-title":"J Am Pharm Assoc","ISSN":"http:\/\/id.crossref.org\/issn\/0003-0465","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1056\/NEJM198707233170402","article-title":"The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: A double-blind, placebo-controlled trial","volume":"317","author":"Richman DD","year":"1987","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1053\/jinf.1999.0628","article-title":"Causes of macrocytosis in HIV-infected Patients not Treated with Zidovudine","volume":"40","author":"Geen\u00e9 D","year":"2000","journal-title":"J Infect","ISSN":"http:\/\/id.crossref.org\/issn\/0163-4453","issn-type":"print"},{"key":"ref13","first-page":"175","article-title":"S\u00edndromes mielodispl\u00e1sticas: diagn\u00f3stico de exclus\u00e3o","volume":"28","author":"Magalhaes-Silvia MM","year":"2006","journal-title":"Rev Bras Hematol Hemoter"},{"key":"ref14","series-title":"Recomenda\u00e7\u00f5es para terapia anti retroviral em adultos e adolescentes infectados pelo HIV","year":"2006"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0025-7125(16)30348-0","article-title":"Human immunodeficiency virus associated anemia","volume":"76","author":"Doukas MA","year":"1992","journal-title":"Med Clin North Am","ISSN":"http:\/\/id.crossref.org\/issn\/0025-7125","issn-type":"print"},{"key":"ref16","first-page":"75","article-title":"Colabamin deficiency in patients infected with the human immunodeficiency virus","volume":"36","author":"Remacha AF","year":"1999","journal-title":"Semin Hematol","ISSN":"http:\/\/id.crossref.org\/issn\/0037-1963","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/ajcn\/77.2.420","article-title":"Vitamin B metabolism in HIV-infected patients in the age of highly active antiretroviral therapy: role of homocysteine in assessing vitamin B12 status","volume":"77","author":"Remacha AF","year":"2003","journal-title":"Am J Clin Nutr","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9165","issn-type":"print"},{"key":"ref18","first-page":"469","article-title":"Evaluation of the polymorphisms in methylenetetrahydrofolate reductase gene and the levels of folate and B12 in HIV infected patients under antiretroviral therapy","volume":"37","author":"Malavazi I","year":"2004","journal-title":"Rev Soc Bras Med Trop","ISSN":"http:\/\/id.crossref.org\/issn\/0037-8682","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/00002030-199905280-00010","article-title":"Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe","volume":"13","author":"Mocroft A","year":"1999","journal-title":"AIDS","ISSN":"http:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"}],"container-title":["Revista da Sociedade Brasileira de Medicina Tropical"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rsbmt\/v44n1\/09.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T03:14:01Z","timestamp":1560136441000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0037-86822011000100009&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0037-86822011000100009"],"URL":"https:\/\/doi.org\/10.1590\/s0037-86822011000100009","relation":{},"ISSN":["0037-8682"],"issn-type":[{"value":"0037-8682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}